The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $57.89

Today's change0.00 0.00%
Updated March 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $57.89

Today's change0.00 0.00%
Updated March 5 4:00 PM EST. Delayed by at least 15 minutes.

Align Technology Inc closed at (U.S.)$57.89.

Over the last five days, shares have gained 2.59% and 3.54% year to date. Shares have underperformed the S&P 500 by 5.06% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $57.89
  • High--
  • Low--
  • Bid / Ask(U.S.) $45.00 / (U.S.) $0.00
  • YTD % change+3.54%
  • Volume0
  • Average volume (10-day)552,568
  • Average volume (1-month)677,647
  • Average volume (3-month)805,195
  • 52-week range(U.S.) $43.27 to (U.S.) $64.75
  • Beta2.03
  • Trailing P/E32.64×
  • P/E 1 year forward34.02×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.77
Updated March 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+19.15%

Based on its net profit margin of 19.15%, Align Technology Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue199190193181
Total other revenue--------
Total revenue199190193181
Gross profit151145145137
Total cost of revenue48454743
Total operating expense147138144139
Selling / general / administrative86818382
Research & development13131313
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income51524942
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax50504942
Income after tax40383632
Income tax, total10111310
Net income40383632
Total adjustments to net income--------
Net income before extra. items40383632
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items40383632
Inc. avail. to common incl. extra. items40383632
Diluted net income40383632
Dilution adjustment--------
Diluted weighted average shares82828283
Diluted EPS excluding extraordinary itemsvalue per share0.480.470.430.39
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.480.470.430.39